Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-17

Clinical Trial Update: Saffron as Anti Inflammatory In Patients With Inflammatory Bowel Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating saffron as an anti-inflammatory treatment in patients with ulcerative colitis is underway but status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Saffron (saffron extract)

Snippet

Sponsor: Minia University | Conditions: Ulcerative Colitis | Phase 4 | Status: UNKNOWN